Literature DB >> 17364675

Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.

Vincent S Fan1, Scott D Ramsey, Barry J Make, Fernando J Martinez.   

Abstract

Using clinical and claims records from the National Emphysema Treatment Trial, we sought to identify factors that accurately predicted COPD exacerbations. This prospective cohort study consisted of subjects with severe emphysema randomized to medical therapy. Exacerbations were defined as a hospitalization or emergency department visit for COPD. Patient characteristics obtained before randomization were entered as independent variables in multivariable logistic regression models to estimate the risk of exacerbation. Discrimination was determined using the area under the receiver operator characteristic curve (AUC). Baseline measures included demographics, body mass index, pulmonary function, arterial blood gases, radiology studies, dyspnea (Shortness of Breath Questionnaire - SOBQ), health-related quality of life (St. George's Respiratory Questionnaire - SGRQ), 6-minute walk, exercise capacity, medication use, prior exacerbations and co-morbidity. In 610 participants, 26.6% had a COPD exacerbation over 1-year follow-up. In a model incorporating spirometry, PaO2, dyspnea, prior exacerbations and co-morbidity, a 5-point decrement in percent predicted FEV1 (OR 1.16, 95% CI 1.00-1.34) and a 5-point worsening in SOBQ (OR 1.08, 1.02-1.14) independently predicted exacerbations (AUC for full model 0.68). Combining physiologic variables, dyspnea, prior exacerbations and co-morbidity may be useful in identifying patients at high risk for COPD exacerbations.

Entities:  

Mesh:

Year:  2007        PMID: 17364675     DOI: 10.1080/15412550601169430

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  22 in total

1.  The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations.

Authors:  George R Washko; Vincent S Fan; Scott D Ramsey; Zab Mohsenifar; Fernando Martinez; Barry J Make; Frank C Sciurba; Gerald J Criner; Omar Minai; Malcolm M Decamp; John J Reilly
Journal:  Am J Respir Crit Care Med       Date:  2007-10-25       Impact factor: 21.405

2.  Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort.

Authors:  Mark D Eisner; Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Paul D Blanc
Journal:  Chest       Date:  2009-12-29       Impact factor: 9.410

Review 3.  Lung volume reduction surgery for diffuse emphysema.

Authors:  Joseph Em van Agteren; Kristin V Carson; Leong Ung Tiong; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

4.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

5.  Quality of well-being outcomes in the National Emphysema Treatment Trial.

Authors:  Robert M Kaplan; Qiankun Sun; Andrew L Ries
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 6.  The evaluation and preparation of the patient for lung volume reduction surgery.

Authors:  Malcolm M DeCamp; David Lipson; Mark Krasna; Omar A Minai; Robert J McKenna; Byron M Thomashow
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  The COPD Helplessness Index: a new tool to measure factors affecting patient self-management.

Authors:  Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Sara J Knight; Paul D Blanc; Mark D Eisner
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

8.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 9.  [Clinical value of forced expiratory volume in 1 s (FEV1) in chronic obstructive pulmonary disease].

Authors:  Adrian Gillissen; Thomas Glaab; Roland Buhl
Journal:  Med Klin (Munich)       Date:  2009-02-26

10.  Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

Authors:  M G Foreman; D L DeMeo; C P Hersh; V J Carey; V S Fan; J J Reilly; S D Shapiro; E K Silverman
Journal:  Eur Respir J       Date:  2008-06-11       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.